Analysts Estimate Labcorp (LH) to Report a Decline in Earnings: What to Look Out for
https://www.zacks.com/stock/news/2223452/analysts-estimate-labcorp-lh-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2223452
Feb 08, 2024 - Labcorp (LH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
Labcorp (LH) Unveils Test for Preeclampsia in Pregnant Women
https://www.zacks.com/stock/news/2219761/labcorp-lh-unveils-test-for-preeclampsia-in-pregnant-women?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2219761
Feb 01, 2024 - Labcorp (LH) test System, which is available through clinicians, is the first FDA-cleared biomarker test to aid in the risk assessment of progression to severe preeclampsia.
0
Quest Diagnostics (DGX) Advances in Cancer Research With New Deal
https://www.zacks.com/stock/news/2216443/quest-diagnostics-dgx-advances-in-cancer-research-with-new-deal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2216443
Jan 26, 2024 - Quest Diagnostics' (DGX) subsidiary Haystack Oncology collaborates with TriSalus Life Sciences to improve therapeutic options for aggressive forms of cancer.
0
LabCorp (LH) to Expand Clinical Trails Access With New Pact
https://www.zacks.com/stock/news/2208988/labcorp-lh-to-expand-clinical-trails-access-with-new-pact?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2208988
Jan 11, 2024 - LabCorp (LH) and Hawthorne Effect hope to enhance decentralized clinical trials by merging existing services and developing fresh, unique service offers.
0
Here's Why Investors Should Retain Labcorp (LH) Stock for Now
https://www.zacks.com/stock/news/2203637/here-s-why-investors-should-retain-labcorp-lh-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2203637
Dec 29, 2023 - Investors remain optimistic about Labcorp (LH) due to impressive partnerships and expansion efforts in targeted high-growth areas.
0
Pages: 12
<Page 2